Marketing Technology (MarTech) API Integrations in Life Sciences

CRM systems in life sciences manage HCP and patient contacts, track interactions, and coordinate field teams. Three leading solutions now compete: Veeva Vault CRM, Salesforce Life Sciences Cloud, and IQVIA OCE. Veeva has reported more than 125 customers live on Vault CRM worldwide, including biopharma companies among the global top 20, with continued additions expected through fiscal 2026 (^[6]). Veeva Vault CRM is architected around U.S. regulations, including 21 CFR Part 11 electronic-records requirements (^[7]) and the Prescription Drug Marketing Act (^[8]), to support compliant management of promotional activities. It provides a single source of HCP data (including product/label data) that reps use via mobile apps, enabling next-best actions, notifications, and secure content delivery. Veeva Vault (PromoMats) manages MLR-approved assets and global campaign "toolkits" that brand teams and field reps use.

A major 2025-2026 development is Veeva AI Agents, announced generally available on December 3, 2025. The initial release includes a Pre-call Agent (insights and suggested actions for field reps), a Media Agent (semantic search across content libraries), a Free Text Agent (detects issues in call notes for accuracy and compliance), and a Voice Agent (voice input for capturing information in Vault CRM), with additional agents for clinical, regulatory, safety, quality, medical, and commercial functions planned through 2026 (^[9]).

Salesforce Life Sciences Cloud for Customer Engagement became generally available on October 11, 2025 (^[10]). It includes Agentforce for Life Sciences, an agentic AI capability that can triage therapeutic and medical information requests with handoff to a human as needed, alongside features such as Smart Summaries, Key Account Management, and Intelligent Content; Podcast Stories and Agentforce Voice are slated for February 2026 (^[10]). Adopters announced to date include Takeda (May 2025) (^[11]), and Novartis and AstraZeneca (December 2025) (^[12]); Salesforce also announced a Life Sciences Partner Network in May 2025 to help accelerate customer migration and implementation (^[13]). Health Cloud's clinical data model aligns with FHIR v4.0.1, mapping roughly two dozen FHIR R4 resources (administration, clinical, medication, diagnostics, workflow) onto Salesforce standard objects to enable data exchange with EHRs (^[14]).

IQVIA OCE continues with OCE+, which layers an AI-driven Next Best Action recommendation engine, built on more than 200 extendible rules- and ML-based algorithms, onto the base OCE platform to suggest HCP-specific engagement timing and channel (^[15]). IQVIA and Salesforce expanded their partnership in 2024 so that IQVIA licenses OCE-related software to Salesforce and the two companies jointly develop Life Sciences Cloud, with IQVIA continuing to support existing OCE customers through 2029 (^[16]). OCE reach is commonly cited at 350+ customers in 130+ countries (^[17]).

Use Case – Veeva + Adobe: Pharma companies increasingly link CRM to marketing content. Adobe's Real-Time CDP is built to ingest event and profile data from third-party systems via its connector library to build unified customer profiles (^[18]), a pattern life sciences marketers apply to combine CRM-sourced HCP attributes with digital engagement data for targeted campaigns. Separately, Veeva Vault PromoMats' Silicon Connector links Adobe InDesign, Photoshop, and Illustrator directly to the Vault repository: when an approved asset changes in Vault, linked InDesign files are automatically flagged and updated, and no content ever leaves Vault PromoMats as the system of record (^[19]).

Marketing Automation Platforms (MAPs) manage campaigns, emails, event invites, lead scoring, and nurture journeys. Key vendors include Adobe Marketo Engage, Salesforce Marketing Cloud Account Engagement (formerly Pardot), Oracle Eloqua, and others like HubSpot (though HubSpot is less common in large pharma, it's popular in healthcare startups). These platforms now primarily offer REST APIs with OAuth 2.0 authentication, the industry-standard authorization framework defined in IETF RFC 6749 (^[20]). Deprecation notice: Adobe’s current guidance sets different retirement dates: Marketo's legacy SOAP API is no longer available after July 31, 2026, while REST API authentication using the access_token query parameter is unavailable after August 31, 2026. Integrations should authenticate REST API calls using the Authorization header (^[21]).

MAPs enable scale and automation of communications: they let marketers reach HCPs across large contact lists and use behavioral scoring to help sales teams prioritize accounts by engagement level (^[1]). Platforms like Marketo provide marketing ops teams with features to identify and engage customers, attract leads via online forms, nurture those leads toward sales-ready status, and track ROI. Importantly, automation works best when linked to CRM. Native connectors (e.g. Marketo's Salesforce connector) or custom integrations synchronize leads, contacts, and activity data. In pharma, a common pattern is: CRM → MAP sync so that field rep data (target lists, account status) flows to marketing; and MAP → CRM sync so that email opens/clicks or lead scores update the CRM records.

Use Case – Veeva CRM + Marketo: A representative integration pattern connects a Salesforce-based CRM such as Veeva CRM to Marketo Engage. When data flows between them, field reps can reach hard-to-reach HCPs via automated Marketo campaigns (e.g. email series, webinars) that deliver content and generate engagement metrics. Conversely, when an HCP engages (e.g. clicks a link), Marketo can flag that behavior and pass it back to the CRM as a next-best-action signal, a pattern consistent with how marketing automation vendors describe behavioral lead scoring for prioritizing HCP outreach (^[1]). This requires API integration using the MAP's REST endpoints, OAuth 2.0 authentication (^[20]), and rule-based logic to route data between systems.

Key features of major MAPs include:

• Marketo Engage (Adobe): REST API for leads, activities, campaigns; built-in lead scoring and multichannel program management; integrations with CRMs (Salesforce, Microsoft) and analytics. A new native Email Designer with an AI Assistant "Content Accelerator" for generating copy, subject lines, and images, plus GenStudio integration for on-brand content, rolled out through 2025 (^[22]).
• Salesforce Marketing Cloud Account Engagement: Salesforce-owned, integrates natively with the Salesforce platform via REST API and bulk API using OAuth 2.0 (^[20]), with email marketing, lead scoring, and B2B marketing attribution. The Spring '26 release introduces up to 50 business units per org, each with its own isolated view for campaigns and reporting, plus an Agentforce Campaign Creation Agent that can draft campaign briefs and generate multi-channel program steps (^[23]).
• Oracle Eloqua: a RESTful Bulk API supporting high-volume transfers of contacts, accounts, custom data objects, and campaign responses, plus a standard REST API, with authentication via HTTP basic auth or OAuth 2.0 (^[24]); form and landing page management, lead scoring, campaign orchestration.
• HubSpot (for healthcare): simpler CRM API for contacts (/crm/v3/objects/contacts) and engagement objects such as emails, calls, meetings, and notes (^[25]), often used for patient outreach or inbound lead generation in medtech.

Each offers API access to contact records, engagement data, and assets. Integration with CRMs is often out-of-the-box (e.g. Salesforce-Account Engagement, Microsoft-Dynamics-Marketo) but may be extended with custom middleware, frequently built on iPaaS platforms such as MuleSoft or Boomi (^[26]).

Content is king in pharma marketing, but must be carefully managed for global regulation. Content platforms include Adobe Experience Manager (AEM) or other CMSs, Digital Asset Management (DAM) systems like Veeva Vault PromoMats, and personalization engines like Adobe Target or A/B testing tools. APIs come into play for delivering content in real time (e.g. AEM's GraphQL/REST APIs for dynamic sites) and for integrating with other systems.

For example, AEM as a Cloud Service offers headless CMS capabilities: developers can use its GraphQL APIs to query content fragments and personalization data on the fly. The 2025.12.0 release (December 11, 2025) provides early access to new agentic capabilities across production, governance, optimization, discovery, and development, surfaced through Adobe applications including Real-Time CDP, AEM, Journey Optimizer, and Customer Journey Analytics (^[27]). In pharma, AEM is often the primary web CMS, and it can pull in data from CRMs or CDPs via APIs to personalize pages.

Meanwhile, Veeva Vault PromoMats (a DAM/marketing authoring tool) ensures MLR compliance. Veeva's December 2025 AI Agents release also included a Quick Check Agent for PromoMats, which scans content against editorial, brand, market, channel, and compliance guidelines before MLR review, and a Content Agent that answers questions about and summarizes document text and images (^[9]). It integrates with various creative and publishing tools: the Silicon Connector links Adobe InDesign, Photoshop, and Illustrator directly to Vault PromoMats so that any change to an approved asset in Vault automatically updates linked InDesign files, with the DAM remaining the single source of truth (^[19]).

Personalization engines such as Adobe Target use APIs (including profile-update and real-time getOffer() calls) or JavaScript tags to deliver dynamic content based on user segments, with auto-allocate and auto-target machine-learning modes that shift traffic toward the best-performing experience during a test (^[28]). These systems often pull HCP segment data from a CDP or CRM API to decide which content variation to show a given visitor.

Robust analytics underpin smart MarTech. Web analytics (Google Analytics 4, Adobe Analytics) and customer analytics (e.g. via a CDP like Tealium or Salesforce CDP) are key. Google Analytics 4 (GA4) continues to evolve with AI-powered capabilities. On December 12, 2025, Google launched Analytics Advisor, an agentic conversational assistant, powered by Gemini models, built into GA4 that lets users ask questions in natural language and receive explanations, visualizations, and key-driver analysis of performance changes (^[29]). Adobe Analytics similarly offers a REST API (Analytics 2.0) with OAuth server-to-server authentication for retrieving reports and metrics programmatically (^[30]). These tools track HCP/patient interactions on digital channels; their data is often pulled via API into dashboards or BI tools.

Pharma also leverages specialized analytics: IQVIA provides HCP/patient databases and performance analytics. IQVIA's OCE+ platform layers an AI-driven Next Best Action recommendation engine onto the OCE CRM to deliver HCP-specific actions, optimal engagement timing, and channel recommendations directly into commercial workflows (^[15]). IQVIA was named a Leader in the Everest Group Life Sciences AI and Analytics Services for Commercial PEAK Matrix® Assessment 2025, alongside other Leaders including Accenture, Indegene, and ZS (^[31]). MarTech analytics often merges digital engagement metrics with these real-world data via APIs or CDPs, yielding unified dashboards.

Given privacy pressure, many firms now build first-party data platforms (CDPs). Tealium for Pharma, marketed as the first pharma-specific CDP solution, ships with pre-built integrations for Veeva, Doceree, and DMD, along with pharma-specific data models and use cases (^[32]). Tealium was named a Leader in the Gartner® Magic Quadrant™ for Customer Data Platforms for the second consecutive year in March 2025 (^[33]). Indegene and Tealium co-created a CDP Starter Kit specifically for life sciences organizations evaluating a CDP investment (^[34]). As third-party cookies decline, life sciences companies increasingly rely on first-party touchpoints (website, CRM data, events) to fuel personalization.

Key Insight: IQVIA's 2025 Everest Group recognition and Tealium's Gartner leadership both reflect the industry's shift toward AI-augmented analytics. Martech integration now links web/mobile analytics, CRM, and AI-driven insights (e.g. predictive propensity models, agentic recommendations) into sales and marketing workflows.

Privacy regulations loom large in healthcare marketing. HIPAA's Privacy Rule requires an individual's written authorization before protected health information (PHI) can be used or disclosed for marketing communications about a product or service (^[35]). Under the EU's GDPR, consent is one of six lawful bases for processing personal data and, to be valid, must be freely given, specific, informed, and given through a clear affirmative action, with withdrawal made as easy as giving it (^[36]). California's CCPA gives consumers the right to know what personal information is collected, to delete it, and to opt out of its sale, enforced by the California Privacy Protection Agency (^[37]). India's Digital Personal Data Protection Act similarly requires free, specific, informed, and unambiguous consent from data principals before processing, with full compliance phased in by mid-2027 (^[38]). Platforms like OneTrust, TrustArc, or industry-focused solutions manage consents and preferences across channels, typically via APIs or webhooks that integrate consent records with other MarTech.

OneTrust was named a Leader in the IDC MarketScape 2025 Worldwide Data Privacy Compliance Software vendor assessment (^[39]). OneTrust launched its Universal Consent and Preference Management platform to centralize consent records collected across web, mobile, and other channels into a single system of record with a consumer-facing preference center (^[40]). A Forrester Consulting Total Economic Impact study commissioned by OneTrust found that a composite organization using its granular consent capabilities improved revenue driven by digital marketing campaigns by 3%, with an overall 227% ROI over three years (^[41]). OneTrust's 2025 governance survey of 1,250 executives found 82% say AI risks have accelerated the need to modernize governance (^[42]).

Syrenis Cassie is a consent management platform used in pharma that centralizes consent data across the clinical development workflow and offers 350+ pre-built API integrations across EHRs, CRMs, and other healthcare systems, supporting compliance with HIPAA, CCPA, and GDPR (^[43]). In practice, Cassie's API lets a pharma IT team push updates (e.g. a doctor's marketing opt-in) into downstream systems so that, say, email lists are automatically filtered.

Similarly, Viseven (a pharma MarTech provider) describes an omnichannel consent-management approach built on granular, purpose- and channel-specific consent, capturing opt-in status through channels such as CLM-connected rep visits, emails, landing pages, and webinar registrations, and centralizing it in the CRM or a dedicated consent platform so permissions are enforced consistently across channels (^[44]). In the integrated stack, consent tools feed preference data to CRM and campaign systems: CRM records can flag which HCPs have opted in to digital outreach, and automation APIs help ensure no communications are sent without proper consent.

Though often treated separately, patient recruitment can leverage MarTech. Digital marketing (search ads, social media, display) is now common for trial outreach. Platforms exist to integrate digital leads into trial management: for example, StudyTeam offers an API that collects patient leads from ads, vendor portals or landing pages and routes them directly to clinical sites. This avoids manual data entry and ensures potential participants “aren’t falling through the cracks”. In practice, marketing teams may run targeted campaigns (often via marketing automation) that push interested patient contacts into such recruitment platforms via their APIs. Integrations can also connect site IT systems (via HL7/FHIR if interfacing with health records) and trial systems, though data standards here are more clinical (e.g. CDISC) than marketing-focused. The key MarTech principle is the same: APIs link campaign data (e.g. a web sign-up) to the trial database in real time, streamlining workflows and improving enrollment.

Pharma marketing is one of the most regulated domains. MarTech integrations must enforce compliance. Leading platforms have built-in compliance features: Veeva Vault CRM is explicitly designed for FDA-regulated promotion (21 CFR Part 11, Prescription Drug Marketing Act, etc.). Adobe Experience Cloud services have different HIPAA designations; PHI may be processed only in services Adobe designates HIPAA-ready or HIPAA-eligible, when they are correctly licensed and configured and a Business Associate Agreement is in place where required (^[45]; Adobe Experience Platform healthcare use cases). Salesforce Life Sciences Cloud, launched October 2025, is built on Hyperforce infrastructure with built-in Trust Layer and zero-copy integration, designed to meet HIPAA, GxP, GDPR, and NHS DCB 0129 standards. A certified Life Sciences Partner Network was announced in May 2025 to accelerate customer migration to this HIPAA-ready, pre-validated, GxP-compliant platform. Integrations thus often use secure protocols (HTTPS, OAuth 2.0 with enterprise SSO, encrypted payloads) and audit trails. For example, eConsent collected via one system might be written into Veeva Vault with an immutable log (via Vault's API or ClinOps integration).

For HIPAA-covered entities and their business associates, the applicable rule is the HIPAA Privacy Rule—not a general FDA prohibition on combining PII and PHI. With limited exceptions, the Rule requires an individual’s written authorization before PHI is used or disclosed for a marketing communication. Teams should determine whether HIPAA applies to the entity and data flow, document the applicable permissions, and limit system access and disclosures accordingly (^[35]).

In summary, every integration in pharma MarTech must consider compliance. This often means choosing platform features (e.g. HIPAA-encrypted fields), using standardized data models (FHIR v4.0.1 for clinical data, ensuring safe exchanges), and embedding consent checks. The emergence of agentic AI in platforms like Agentforce for Life Sciences includes AI-enabled compliance enforcement to help avoid misinformation, maintain brand reputability, and maximize revenue. Successful implementations report that a modern MarTech stack, when well-integrated, improves compliance by automating consistent governance across channels.

The tables below summarize representative platforms in each category, their API characteristics, and typical integration use cases in pharma marketing (updated January 2026).

Table: Representative MarTech platforms and integration highlights in life sciences (updated January 2026).

• REST vs. GraphQL: Most modern MarTech APIs are RESTful (JSON over HTTP, with OAuth2). Some platforms now offer GraphQL for richer, client-driven queries (e.g. Salesforce's Customer 360 GraphQL API). SOAP (XML) is being deprecated – notably, Marketo SOAP API support ends July 31, 2026. In practice, pharma IT teams favor REST JSON for its simplicity and wide SDK support.
• Authentication: OAuth 2.0 (with client credentials or authorization code flows) is standard for cloud MarTech APIs, often via SSO (SAML/OIDC). VPN or private connections may be used for extra-secure systems (e.g. integrating on-premise systems with cloud CDPs). Note: Marketo’s access_token query parameter will not be available after August 31, 2026; integrations should use the Authorization header.
• Data Standards: HL7 FHIR v4.0.1 is used when exchanging clinical/patient data (Salesforce Healthcare API, Health Cloud). For HCP identification, pharma uses proprietary IDs (e.g. IQVIA OneKey). Marketing data (campaigns, clicks) typically use no industry standard beyond JSON events. However, ensuring consistent schema (field names, codes) across systems is crucial for API mapping.
• Orchestration: Integration layers or iPaaS (e.g. Mulesoft, Boomi) are often used to route data and transform it between systems. iPaaS solutions are increasingly recognized as the "holy grail" of the MarTech ecosystem, offering user-friendly self-service functionalities, pre-built connectors, and robust automation capabilities. For example, a middleware might listen to a webhook from Marketo, transform the payload, and call the Veeva API to update a record.
• CDPs and Data Hubs: Given data silos, many life sciences companies build a "MarTech spine" or CDP. Platforms like Tealium for Pharma (with built-in Veeva, Doceree, DMD integrations) or Salesforce CDP ingest events from websites and fields, unify identities, and then push segments to downstream tools (advertising, email, rep apps). This decouples individual integrations by having one central API-driven hub.
• Agentic AI Integration: As of 2026, agentic AI has moved from pilot mode into full-scale deployment. Platforms like Agentforce for Life Sciences, Veeva AI Agents, and IQVIA OCE+ now provide AI-driven recommendations directly in workflows. Integration architecture should account for AI agent capabilities including natural language interfaces, voice input, and automated next-best-action recommendations.

In U.S. pharmaceuticals, integrating MarTech systems via APIs is critical to modern, compliant marketing. The landscape has transformed significantly in 2025-2026 with the emergence of agentic AI across all major platforms. Leading companies now stitch together CRM (Veeva Vault CRM, Salesforce Life Sciences Cloud, IQVIA OCE+), marketing automation (Marketo, Account Engagement), content (Adobe AEM, Veeva Vault), analytics, and consent tools to create an omnichannel experience for HCPs and patients. The trend is towards data unification: robust CDPs like Tealium for Pharma and advanced APIs enable real-time personalization while respecting strict privacy/regulations.

Major developments in this period include:

• Veeva AI Agents (free through 2030) with Pre-call, Media, Free Text, and Voice capabilities
• Salesforce Life Sciences Cloud with Agentforce, adopted by Novartis, AstraZeneca, and Takeda
• IQVIA OCE+ with AI-driven Next Best Action, with customers supported through 2029
• Deprecation of legacy APIs (Marketo SOAP API ending July 31, 2026; access_token query-parameter authentication ending August 31, 2026)
• Pharma-specific CDPs like Tealium for Pharma with built-in compliance

The global pharmaceutical CRM market, valued at $4.33 billion in 2024, is projected to reach $9.85 billion by 2034, while AI in pharma is expected to grow from $1.9 billion to over $16 billion in the same period. As one thought leader notes, a fully empowered field team using a unified tech stack can "unlock new levels of agility, compassion and personalization" in life sciences marketing. IT and marketing teams must stay agile, continuously integrating emerging AI-powered tools while maintaining compliance to stay ahead in the competitive U.S. pharma market.

Sources: Industry reports, vendor docs, and expert blogs were used throughout. Key references include Everest Group on life sciences commercial tech and AI analytics, ZS insights on pharma CRM, Adobe and Veeva partnership announcements, Tealium/Indegene CDP Starter Kit, Salesforce Life Sciences Cloud documentation, Veeva AI Agents announcements, Custom Market Insights and Research and Markets on pharma CRM market size, OneTrust on consent management, and Gartner Magic Quadrant for CDPs. Each table entry and insight is supported by these sources.